For the first time, an Earth observation satellite has found what it was looking for — on its own, without human analysts on the ground. The milestone, which occurred in April, marks the first ...

One of the world’s leading artificial intelligence companies has implored the industry to pause development on AI, because the latest models could be reaching a tipping point where they become capable ...

Credit: Ben Goldstein/Aviation Week BURLINGTON, Vermont—Beta Technologies took a rare step out of its traditionally low-profile approach this week, inviting journalists from a host of ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

RSI is also defined as an “AI system capable of fully autonomously designing and developing its own successor,” per Anthropic’s blog post. “We are not there yet, and recursive self-improvement is not ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Nick Caloway is a multi-skilled journalist who was thrilled to join the CBS News New York news team in August 2019. Since then, Nick has covered crime, politics, the pandemic and more across the ...

Anti-ICE agitators and pro-ICE counter-protesters gathered at Newark's Delaney Hall as state police assume public safety responsibilities. Tensions remain high after clashes between agitators and ...

Viasat, TTP, and Frequentis conduct Iris Remotely Piloted Aircraft Systems (RPAS) trial: examining future satellite connectivity and traffic management integration for BVLOS operations within managed ...

Protesters continued demonstrations at Newark, New Jersey's Delaney Hall detention facility Tuesday, clashing with U.S. Immigration and Customs Enforcement (ICE) agents as they carried weekend ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...